QTZM — Quantumzyme Income Statement
0.000.00%
- $174.94m
- $174.94m
Annual income statement for Quantumzyme, fiscal year end - July 31st, AFN millions except per share, conversion factor applied.
2025 July 31st | |
|---|---|
| Period Length: | 12 M |
| Source: | 10-K |
| Standards: | USG |
| Status: | fx Final |
| Total Revenue | 0 |
| Selling / General / Administrative Expenses | |
| Unusual Expense / Income | |
| Total Operating Expenses | 12.5 |
| Operating Profit | -12.5 |
| Total Net Non Operating Interest Income / Expense | |
| Net Income Before Taxes | -14 |
| Provision for Income Taxes | |
| Net Income After Taxes | -14 |
| Net Income Before Extraordinary Items | |
| Net Income | -14 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |
| Income Available to Common Shareholders Including Extraordinary Items | |
| Diluted Net Income | -14 |
| Diluted Weighted Average Shares | |
| Basic EPS Including Extraordinary Items | |
| Diluted EPS Including Extraordinary Items | |
| Diluted EPS Excluding Extraordinary Items | |
| Normalised Income Before Taxes | |
| Normalised Income After Taxes | |
| Normalised Income Available to Common Shareholders | |
| Diluted Normalised EPS | -0.404 |